Andere Kunden interessierten sich auch für
![Current Management of Invasive Bladder and Upper Tract Urothelial Cancer, an Issue of Urologic Clinics]( "Current Management of Invasive Bladder and Upper Tract Urothelial Cancer, an Issue of Urologic Clinics")
Current Management of Invasive Bladder and Upper Tract Urothelial Cancer, an Issue of Urologic Clinics130,99 €![Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: An Update, an Issue of Urologic Clinics]( "Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: An Update, an Issue of Urologic Clinics")
Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer: An Update, an Issue of Urologic Clinics117,99 €![Management of High Grade Bladder Cancer: A Multidisciplinary Approach, an Issue of Urologic Clinics]( "Management of High Grade Bladder Cancer: A Multidisciplinary Approach, an Issue of Urologic Clinics")
Management of High Grade Bladder Cancer: A Multidisciplinary Approach, an Issue of Urologic Clinics117,99 €![Prostate Cancer Genetics: Changing the Paradigm of Care, an Issue of Urologic Clinics]( "Prostate Cancer Genetics: Changing the Paradigm of Care, an Issue of Urologic Clinics")
Prostate Cancer Genetics: Changing the Paradigm of Care, an Issue of Urologic Clinics130,99 €![Minimally Invasive Urology: Past, Present, and Future, an Issue of Urologic Clinics]( "Minimally Invasive Urology: Past, Present, and Future, an Issue of Urologic Clinics")
Minimally Invasive Urology: Past, Present, and Future, an Issue of Urologic Clinics130,99 €![Men's Health, an Issue of Urologic Clinics]( "Men's Health, an Issue of Urologic Clinics")
Men's Health, an Issue of Urologic Clinics117,99 €![Vasectomy and Vasectomy Reversal: Important Issues, an Issue of Urologic Clinics]( "Vasectomy and Vasectomy Reversal: Important Issues, an Issue of Urologic Clinics")
Vasectomy and Vasectomy Reversal: Important Issues, an Issue of Urologic Clinics117,99 €
Together with Consulting Editor Dr. Samir Taneja, Dr. Badrinath Konety has put together a comprehensive issue that addresses Salvage therapies for Non-Muscle Invasive Bladder Cancer. Expert authors have contributed clinical review articles on the following topics: BCG salvage therapy: Definition and context; Who will respond to BCG? Predictors and nomograms; Identification of candidates for salvage therapy: Definition of BCG "Failure?; Predictors of response to Intravesical therapy; Precision medicine for NMIBC; Salvage therapy using BCG derivatives or single agent chemotherapy; Intravesical heated Mitomycin: Biology and clinical utility; Mitomycin derivatives in the salvage setting; Combination intravesical therapy; Intravesical gene therapy; Immunoncology as salvage therapy; Role of IDO inhibitors in salvage therapy; and Novel agents for intravesical therapy. Readers will come away with the clinical information they need to improve outcomes in patients with bladder cancer.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.